Table 3.
Multivariate analysis of risk factors associated with negative conversion time of SARC-CoV-2 from symptom onset in COVID-19 patients.
| P value | OR (95% CI) | |
|---|---|---|
| Female | 0.936 | 0.896 (0.060 ~ 13.324) |
| Age | 0.087 | 7.305 (0.749 ~ 71.283) |
| Fever | 0.778 | 1.457 (0.106 ~ 19.977) |
| Fatigue | 0.923 | 0.834 (0.021 ~ 33.843) |
| Chest distress/breath shortness | 0.011 | 4.011 (1.333 ~ 9.455) |
| Corticosteroid | 0.257 | 4.011 (0.363 ~ 44.366) |
| Mechanical ventilation | 0.210 | 0.014 (0.001 ~ 10.898) |
| Severity assessment on admission | 0.366 | 3.681 (0.219 ~ 61.950) |
| Leukocytes | 0.511 | 2.501 (0.163 ~ 38.365) |
| Neutrophils | 0.692 | 0.453 (0.009 ~ 22.895) |
| Lymphocytes | 0.070 | 13.773 (0.807 ~ 234.951) |
| CD3 + lymphocytes | 0.280 | 0.155 (0.005 ~ 4.543) |
| CD3 + CD4+ lymphocytes | 0.199 | 0.106 (0.003 ~ 3.246) |
| CD3 + CD8+ lymphocytes | 0.230 | 6.760 (0.299 ~ 153.019) |
| CD19 + lymphocytes | 0.109 | 4.709 (0.708 ~ 31.304) |
| CD16 + CD56 + lymphocytes | 0.097 | 0.152 (0.016 ~ 1.408) |
| CRP | 0.305 | 0.237 (0.015 ~ 3.694) |
| ESR | 0.837 | 0.765 (0.080 ~ 9.889) |
| ALB | 0.191 | 5.501 (0.427 ~ 70.941) |
| GLB | 0.543 | 0.533 (0.070 ~ 4.050) |
| GGT | 0.144 | 10.082 (0.455 ~ 223.502) |
| Creatinine kinase | 0.886 | 0.842 (0.080 ~ 8.840) |
| LDH | 0.557 | 0.465 (0.036 ~ 6.004) |
| NCD4LR | 0.029 | 2.575 (1.276 ~ 3.468) |
COVID-19, coronavirus disease 2019; OR, odds ratio; CI, confidence interval; NCD4LR, neutrophil to CD4+ lymphocyte ratio; AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALB, albumin; GLB, globulin; GGT, glutamyltranspetidase; LDH, lactate dehydrogenase; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate.